Market Research Report of Metabolic Disorder Therapeutics Market: Global Product Intelligence Industry 2022

Infinium Global Research has added a new report on Global Metabolic Disorders Therapeutics Market. The report predicts the market size of Metabolic Disorders Therapeutics is expected to reach XX billion by 2022

 

In 2014, the Global Metabolic Disorder Therapeutics Market size was valued USD XX billion. While in 2015, the market size of metabolic disorder therapeutics was valued over USD XX million. The global metabolic disorder therapeutics market is projected to grow with a CAGR between 4.8% and 5.3% over the forecast period of 2016-2022 and reach USD 200 billion by 2022. Metabolism is a process in which human body generates energy from the food humans eat. The food that humans consume comprises proteins, carbohydrates, and fats. Chemicals in human digestive system break the food parts down into sugars and acids. Metabolic disorders occur when abnormal chemical reactions in human body disturb this process. This is due to enzyme deficiency: as all processes in the body are controlled by enzymes. Any disturbance in the pathways involved in the development and metabolism of carbohydrates, proteins, and fats, leads to metabolic disorder.

 

Segments Covered.

 

The report segments the metabolic disorder therapeutics market by types of disease and by region. Market segmentation based on types of disease includes diabetes, obesity, hypercholesterolemia and lysosomal storage disease. Among segments given above, diabetes drug segment was the leading segment and accounted for highest market share over 64% globally in 2015. The increasing diabetic population across the globe is one of the significant factors propelling the growth of this segment.

 

Companies Profiled:

 

  • Novo Nordisk
  • Sanofi
  • Merck
  • AstraZeneca
  • Eli Lily
  • AbbVie
  • Actelion Pharmaceuticals
  • Amicus Therapeutics
  • Arena Pharmaceuticals
  • Astellas Pharma
  • Biocon
  • Biospherics
  • Boehringer Ingelheim
  • CKD Bio
  • Concord Biotech
  • ConjuChem
  • CureDm
  • CymaBay Therapeutics
  • Daewoong
  • Daiichi Sankyo
  • Dance Biopharm
  • DiaMedica

 

Key Topics Covered:

  1. Report Overview
  2. Executive Summary
  3. Metabolic Disorders Therapeutics Market Overview
  4. Global Metabolic Disorders Therapeutics Market, by Disease Type, (USD Million) 2014 – 2022
  5. Global Metabolic Disorders Therapeutics Market, by Region, (USD Million) 2014 – 2022
  6. Company Profiles

 

Click below to access full report @ http://bit.ly/2qBPPDh